Spruce Biosciences, Inc. (SPRB)
60.78
-2.52
(-3.98%)
USD |
NASDAQ |
Aug 28, 16:00
60.60
-0.18
(-0.30%)
After-Hours: 20:00
Spruce Biosciences Total Assets (Quarterly) : 102.85M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 102.85M |
| March 31, 2026 | 56.17M |
| December 31, 2025 | 53.02M |
| September 30, 2025 | 15.31M |
| June 30, 2025 | 21.82M |
| March 31, 2025 | 31.65M |
| December 31, 2024 | 45.21M |
| September 30, 2024 | 65.10M |
| June 30, 2024 | 75.52M |
| March 31, 2024 | 87.54M |
| December 31, 2023 | 103.95M |
| September 30, 2023 | 112.98M |
| June 30, 2023 | 125.96M |
| March 31, 2023 | 139.11M |
| Date | Value |
|---|---|
| December 31, 2022 | 85.65M |
| September 30, 2022 | 95.30M |
| June 30, 2022 | 104.52M |
| March 31, 2022 | 114.99M |
| December 31, 2021 | 126.49M |
| September 30, 2021 | 135.09M |
| June 30, 2021 | 143.45M |
| March 31, 2021 | 153.99M |
| December 31, 2020 | 162.88M |
| September 30, 2020 | 78.48M |
| June 30, 2020 | 38.97M |
| March 31, 2020 | |
| December 31, 2019 | 4.692M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 32.09B |
| PTC Therapeutics, Inc. | 3.250B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.12M |
| Shareholders Equity (Quarterly) | 83.73M |
| Debt to Equity Ratio | 0.0916 |
| Current Ratio | 9.227 |
| Net Debt Paydown Yield | -0.72% |